Skip to main content

Table 5 Relation between medication adherence score and some demographic and clinical data, HAQ-DI level, depression score, anxiety score, DAS-28 level, and socio-economic class among studied patients (No. = 73)

From: Medication adherence to disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis at Assiut University Hospital, Egypt

Items

Medication adherence score

P value

No.

Mean rank

Demographic characteristics

Age (years)

  < 40

12

33.17

0.7

  40–< 50

18

41.58

  50–< 60

23

35.91

  ≥ 60

20

36.42

Occupation

  Housewife

66

37.12

0.74

  Retired

1

16.00

  Free business

2

43.00

  Unemployed

4

37.25

Disease duration (years)

  < 10

30

34.32

0.18

  10–20

28

35.23

  > 20

15

45.67

HAQ-DI level

 Mild (0–< 1)

35

32.80

0.22

 Moderate (1–< 2)

18

42.31

 Severe (2–3)

20

39.58

Depression score

 No case (0–7)

36

36.83

0.95

 Borderline (8–10)

14

38.50

 Case (11–21)

23

36.35

Anxiety score

 No case (0–7)

45

36.21

0.05*

 Borderline (8–10)

12

48.96

 Case (11–21)

16

30.25

DAS-28 level

 Remission < 2.6

6

46.50

0.6

 Low (2.6–< 3.2)

15

36.77

 Moderate (3.2–5.1)

33

34.89

 High > 5.1

19

37.84

Socio-economic class

 Low

15

35.50

0.82

 Middle

45

38.17

 High

13

34.69

  1. No. number, HAQ-DI Health Assessment Questionnaire Disability Index, DAS Disease Activity Index
  2. Kruskal-Wallis (non-parametric) test was used
  3. *Statistically significant difference (P < 0.05)